The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Inclusion Criteria:

Inclusion criteria for patients in Cohort 1

• Age 18 years or older;
• completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders
• Age 18 years or older;
• experience with the delivery of BCG delivery for more than 2 years

Cohort 2 inclusion criteria

• Age 18 years or older;
• diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy

Exclusion Criteria:

Cohort 1 exclusion criteria

• inability to provide informed consent

Cohort 2 exclusion criteria

• inability to provide informed consent
• inability to undergo catheterization (i.e. - history of urethral stricture)
• inability to receive BCG therapy (i.e. - previous reaction with BCG)
• no access to mobile phone
• inability to respond to written conversations in English